Eye Drops for Dogs: When They're Needed and How to Administer Safely

Eye drops are a common treatment for canine eye conditions including conjunctivitis, keratoconjunctivitis sicca (dry eye), corneal ulcers, and uveitis. This article explains the conditions that require eye drops, the main types of medication used, and a practical method for administering drops safely at home. The central rule is that no eye medication should be placed in a dog's eye without a veterinary diagnosis, because many eye conditions look similar but require opposite treatments. Using the wrong drop can worsen an ulcer or delay treatment for a sight-threatening problem.

At a Glance: Common Canine Eye Conditions and Medication Types

The table below summarizes common eye conditions in dogs, the general class of eye drop used, and the reason for treatment. This table is for orientation only. It does not replace a veterinary examination.

Understanding the Canine Eye and Why Drops Are Used

The dog eye has the same basic structure as the human eye. The cornea is the clear front surface, the conjunctiva is the pink membrane lining the eyelids, and the tear film coats the ocular surface to keep it moist and protected. Eye drops deliver medication directly to these tissues, which allows a high concentration of drug at the site of disease with less systemic exposure.

The tear film contains proteins that defend the ocular surface. In dogs with keratoconjunctivitis sicca, the tear film changes in composition as well as quantity. One study found that total tear protein concentration was significantly higher in dogs with KCS than in healthy dogs, and that high-molecular-weight proteins were upregulated while low-molecular-weight protective proteins were reduced or absent. This means dry eye is a qualitative problem in addition to a quantitative one, and it explains why affected dogs develop chronic inflammation and corneal damage even when the eye looks only mildly dry.

Eye drops are used for three broad purposes. The first is to treat infection with antibiotic drops. The second is to reduce inflammation with anti-inflammatory or immunomodulating drops. The third is to lubricate and protect the ocular surface with artificial tear products. Some conditions require more than one type of drop, and the order and frequency of administration matter.

Conditions That Require Eye Drops

Conjunctivitis

Conjunctivitis is inflammation of the conjunctiva. It is one of the most common reasons owners seek veterinary care for a dog's eye. Signs include redness of the pink tissues around the eye, discharge that may be clear, mucoid, or purulent, and squinting. Conjunctivitis can be caused by bacteria, viruses, allergens, irritants, or underlying dry eye.

Antibiotic eye drops are prescribed when a bacterial infection is confirmed or strongly suspected. Anti-inflammatory drops may be used when the cause is allergic or immune-mediated. The danger is that conjunctivitis can look identical to more serious conditions such as corneal ulcers or uveitis. A dog with a corneal ulcer may show only redness and discharge in the early stages. Placing a corticosteroid drop on an ulcerated cornea can delay healing and allow infection to spread deep into the eye.

Keratoconjunctivitis Sicca (Dry Eye)

Keratoconjunctivitis sicca is a common immune-mediated disease in dogs. It is characterized by aqueous tear deficiency, ocular surface inflammation, and risk of vision loss. The condition is diagnosed with the Schirmer tear test, which measures tear production over one minute. Dogs with KCS produce insufficient tears, leading to a dry, inflamed cornea and conjunctiva.

The mainstay of treatment is topical immunomodulating medication. Cyclosporine eye drops have been used for decades to treat canine KCS. A 1989 study of 36 sequential cases found that topical cyclosporine increased tear production by 5 mm/min or greater in all cases of spontaneous KCS with an initial Schirmer tear test value greater than 2 mm/min, and in 59% of eyes with an initial value of 0 to 2 mm/min. The same study documented marked regression of chronic corneal neovascularization and granulation tissue, reduced mucopurulent conjunctivitis, and faster healing of nonhealing corneal ulcers.

Tacrolimus is another immunomodulating agent used for KCS. A 2016 study compared 0.75% cyclosporine drops given three times daily with 0.02% tacrolimus drops given twice daily in 40 dogs with idiopathic KCS. Both treatments significantly reduced corneal neovascularization after the first and second months. In moderate and advanced stages, the observed efficacy of tacrolimus was higher. Across all patients, tacrolimus produced a significant increase in Schirmer tear test values after both the first and second month, while cyclosporine produced a significant increase only after two months.

Pimecrolimus has also been evaluated. A 2009 open-label multicenter study enrolled 44 dogs with KCS and compared 1% pimecrolimus oily eye drops with cyclosporine A ointment, both given twice daily for eight weeks. The mean increase in Schirmer tear test was 9.2 mm/min in the pimecrolimus group and 5.8 mm/min in the cyclosporine group. The improvement in clinical signs of inflammation was significantly greater with pimecrolimus. The study concluded that pimecrolimus was as safe as and more effective than cyclosporine ointment in controlling KCS.

The vehicle used to carry the medication matters. A 2018 study compared 0.03% tacrolimus eye drops diluted in olive oil versus linseed oil in 40 dogs with bilateral KCS. Clinical signs, corneal ulcers, Schirmer tear test values, and tear film break-up time improved in both groups after one month. The decrease in neutrophil count was significantly greater in the linseed oil group. The study concluded that linseed oil may be considered an alternative diluent for tacrolimus eye drops.

Newer formulations continue to be investigated. A liposomal formulation of cyclosporine A dispersed in sodium hyaluronate was evaluated in dogs with dry eye disease. Ocular surface parameters, particularly Schirmer test values, improved significantly after two months of treatment, with values rising from below 13 mm/min before treatment to higher than 15 mm/min in all animals after treatment. A 2026 study of 0.2% cyclosporine therapy in 33 dogs with KCS found that cyclosporine significantly increased Schirmer tear test values in all disease grades and improved selected clinical signs. Neutrophils were the only inflammatory cells to significantly decrease after treatment.

Topical mesenchymal stem cell therapy has been explored as an alternative for dogs that do not respond to immunosuppressant treatment. A 2022 study developed eye drops of allogeneic canine adipose-derived mesenchymal stem cells and treated KCS patients once per week for six consecutive weeks. The quantity and quality of tears improved significantly based on Schirmer tear test and tear break-up time. More than half of all patients improved in tear quantity, and 56.5% of patients that were unresponsive to prior immunosuppressant therapy had an effective increase in tear volume.

One important clinical observation is that immunomodulating treatment for KCS is usually lifelong. A 2021 study examined the effect of withdrawing chronic topical immune modulating treatment in 14 dogs with dry eye disease. After discontinuation, 50% of eyes maintained Schirmer tear test values above 10 mm/min during a follow-up period averaging 136 days. The other 50% showed a decrease from a mean of 15.9 mm/min to 6.1 mm/min, with the time to drop below 10 mm/min averaging 21 days. Severe clinical signs and low baseline Schirmer tear test values before treatment predicted a faster decline after withdrawal. Owners should expect that stopping treatment will likely lead to recurrence of dry eye.

Corneal Ulcers

A corneal ulcer is a defect in the cornea that exposes the underlying stroma. It is painful and sight-threatening. Causes include trauma, foreign bodies, infection, and inadequate tear film. Signs include squinting, excessive tearing, redness, and a visible depression or opacity on the cornea. A fluorescein stain test performed by a veterinarian confirms the diagnosis by staining the ulcerated area green.

Antibiotic eye drops are the cornerstone of ulcer treatment. They prevent bacterial infection of the exposed corneal stroma, which can lead to melting ulcers and perforation. Atropine drops may be added to relieve the painful spasm of the ciliary muscle inside the eye. Corticosteroid drops are absolutely contraindicated in the presence of a corneal ulcer because they suppress the healing response and increase the risk of corneal melting.

Uveitis

Uveitis is inflammation of the vascular layer of the eye. It causes pain, redness, a cloudy cornea, a constricted pupil, and low intraocular pressure. Uveitis can be caused by trauma, infection, immune-mediated disease, or tumors. Anti-inflammatory drops, particularly corticosteroids, are used to control inflammation and prevent complications such as glaucoma and cataract formation. Atropine may be used to dilate the pupil and reduce pain.

Nictitans Plasmacytic Conjunctivitis

Nictitans plasmacytic conjunctivitis is an immune-mediated inflammation of the third eyelid gland. It is seen most commonly in German Shepherd Dogs. A 1999 study treated 13 dogs with 2.0% cyclosporine drops in one eye and 0.1% dexamethasone ointment in the other eye. There were no significant differences between the treatments in remission of clinical signs, reduction of inflammatory infiltrate, or time to recurrence. The dexamethasone-treated eyes tended to recover more rapidly, while the cyclosporine-treated eyes tended to be protected from recurrence for longer.

Cherry Eye

Cherry eye is the prolapse of the third eyelid gland. It appears as a dark pink to reddish mass at the inner corner of the eye. A 2013 case report described an 18-month-old Cocker Spaniel with cherry eye that was treated by massaging the gland back into place followed by administration of eye drops. The treatment was successful with no recurrence at three months follow-up. Cherry eye is often managed surgically, but mild cases may respond to conservative treatment.

Types of Eye Drops

Antibiotic Drops

Antibiotic eye drops are used to treat or prevent bacterial infection of the conjunctiva, cornea, or internal eye. Common examples include drops containing neomycin, bacitracin, polymyxin B, gentamicin, tobramycin, or fluoroquinolones. The choice of antibiotic depends on the suspected organism, the severity of the infection, and the results of any culture and sensitivity testing. Antibiotic drops are typically used several times daily for a defined course. Owners should complete the full course even if the eye looks better.

Lubricating Drops

Lubricating drops, also called artificial tears, are used to supplement the tear film in dogs with mild dry eye or as an adjunct to immunomodulating treatment. They provide temporary relief from dryness and protect the corneal surface. Lubricating drops do not treat the underlying inflammation of KCS. They are a supportive therapy, not a disease-modifying treatment.

Anti-Inflammatory and Immunomodulating Drops

Anti-inflammatory drops include corticosteroids such as dexamethasone and prednisolone, and nonsteroidal anti-inflammatory drugs. These are used for uveitis, allergic conjunctivitis, and other inflammatory conditions. Corticosteroids are potent and effective but must never be used on a cornea with an ulcer.

Immunomodulating drops include cyclosporine, tacrolimus, and pimecrolimus. These are used primarily for KCS and other immune-mediated ocular surface diseases. They work by suppressing the T-cell mediated inflammation that damages the lacrimal glands and ocular surface. They are slow-acting and may take weeks to show full effect. They are typically used long-term.

Other Drops

Atropine drops are used to dilate the pupil and relieve pain in conditions such as corneal ulcers and uveitis. They cause photophobia because the dilated pupil lets in more light. Atropine can have systemic effects if absorbed, including reduced gastrointestinal motility.

Bevacizumab, an anti-vascular endothelial growth factor agent, has been studied as a topical treatment for corneal neovascularization in dogs. A pilot study of 14 eyes from nine dogs with chronic corneal neovascularization found that 0.25% bevacizumab drops given twice daily for 28 days produced statistically significant improvements in conjunctival hyperemia and chemosis in both preserved and unpreserved groups. No significant changes in intraocular pressure, tear production, or systemic VEGF levels were observed. The study concluded that both formulations were safe and well tolerated, but larger studies are needed.

Why Veterinary Diagnosis Is Essential Before Using Any Eye Drop

The single most important safety rule is that no eye medication should be used without a veterinary diagnosis. There are several reasons for this.

First, many eye conditions look alike. Conjunctivitis, corneal ulcers, uveitis, and glaucoma can all cause a red, painful eye. The treatments are different and sometimes opposite. Corticosteroids are used for uveitis but are harmful in corneal ulcers. Glaucoma requires pressure-lowering medication, not antibiotics. A misdiagnosis can lead to permanent vision loss.

Second, human eye drops are not safe substitutes for veterinary products. Human formulations may contain preservatives, active ingredients, or concentrations that are irritating or toxic to the canine eye. Some human glaucoma medications are highly toxic to dogs. The World Organisation for Animal Health emphasizes that animal health and welfare depend on appropriate veterinary care and responsible medication use. Owners should never use human eye drops on a dog without explicit veterinary direction.

Third, some eye conditions are manifestations of systemic disease. Dry eye can be associated with immune-mediated conditions. Uveitis can be caused by infectious diseases such as leptospirosis, ehrlichiosis, or fungal infections. Treating the eye without addressing the underlying cause will not resolve the problem.

Fourth, eye pain can cause dogs to resist handling, and a struggling dog can injure its own eye or bite the person attempting treatment. A veterinary examination can identify the cause of pain and provide appropriate analgesia.

How to Administer Eye Drops Safely

Preparation

Wash your hands thoroughly before handling the medication or touching the dog's face. Gather the medication bottle, a clean towel, and a treat for positive reinforcement. Check the medication label to confirm it is the correct product and that it has not expired. Shake the bottle if the label instructs you to do so. Some suspensions require shaking to resuspend the active ingredient.

Choose a location with good lighting and a non-slip surface. If the dog is small, place it on a table. If the dog is large, work on the floor. Have a second person available to help restrain the dog if needed. A calm, quiet environment reduces stress for both the dog and the handler.

Restraint

The goal of restraint is to keep the dog still without putting pressure on the neck or eyes. For most dogs, standing or sitting with the head gently lifted is sufficient. One hand can be placed under the chin to steady the head. The other hand holds the medication bottle.

For dogs that resist, a second person can stand behind the dog and gently hold the chest or place an arm under the neck. Never squeeze the throat. Never hold the dog by the scruff in a way that causes the eyelids to pull tight. This makes administration harder and increases the risk of injury.

Administration Technique

Hold the bottle in your dominant hand between your thumb and index finger. Rest the base of that hand on the dog's head so that if the dog moves, your hand moves with it. This prevents the bottle tip from striking the eye.

Use the other hand to gently open the upper eyelid by placing your thumb at the top of the eyelid and lifting. You do not need to touch the eye itself. The lower eyelid can be pulled down slightly to create a small pocket.

Hold the bottle tip close to the eye but do not touch the eye, the eyelid, or the eyelashes. Touching the eye with the bottle tip can contaminate the bottle and injure the cornea. Squeeze the prescribed number of drops into the pocket formed by the lower eyelid. Release the eyelid and allow the dog to blink. Blinking spreads the medication across the ocular surface.

If the dog blinks or shakes its head and the drop misses the eye, wait a few minutes and try again. Do not double the dose to compensate for a missed drop unless your veterinarian has instructed you to do so.

After Administration

Praise the dog and offer a treat. This builds a positive association with the procedure. Wipe any excess medication from the fur around the eye with a clean, damp cloth. Do not rub the eye.

If more than one type of eye drop is prescribed, wait at least five minutes between different medications. This prevents the second drop from washing out the first. If both an ointment and a drop are prescribed, administer the drop first and the ointment second.

Storage and Handling

Store eye drops according to the label instructions. Some medications require refrigeration. Others must be kept at room temperature. Keep the bottle tightly capped when not in use. Do not share eye drops between animals or between the dog and any human. Discard the medication after the course is complete or after the expiration date, whichever comes first.

Records and Measurements

Keeping records of eye treatment helps you track response and communicate with your veterinarian. Record the date and time of each dose, the eye treated, and any difficulty with administration. Note any changes in the dog's signs, including redness, discharge, squinting, or pawing at the eye.

For dogs with KCS, the Schirmer tear test is the standard measurement of tear production. It is performed by placing a small strip of filter paper in the lower eyelid for one minute and measuring the length of wetting. Normal values are typically above 15 mm/min. Values below 10 mm/min are consistent with dry eye. Your veterinarian will perform this test at diagnosis and at recheck examinations to monitor response to treatment.

Tear film break-up time is another measurement used to assess tear quality. It measures how quickly the tear film destabilizes after a blink. Short break-up times indicate an unstable tear film, which is common in KCS.

Owners can track clinical signs at home using a simple scale. For example, score discharge, redness, squinting, and corneal appearance from 0 (normal) to 3 (severe) each day. This provides a record of improvement or deterioration that is useful to your veterinarian.

Common Failure Patterns in Eye Drop Treatment

Stopping Treatment Too Early

Immunomodulating treatment for KCS is long-term. The 2021 withdrawal study showed that half of eyes maintained tear production after stopping treatment, but the other half declined to below 10 mm/min within about three weeks. Owners who stop treatment because the eye looks better risk a relapse that may be more severe than the original disease.

Using the Wrong Medication

Placing a corticosteroid drop on a corneal ulcer is one of the most damaging errors in veterinary ophthalmology. It suppresses the healing response and can lead to corneal melting and perforation. This is why veterinary diagnosis is essential before any eye medication is used.

Contaminating the Bottle

Touching the bottle tip to the eye, eyelid, or any surface contaminates the medication. Contaminated drops can introduce bacteria into the eye. If the tip touches anything, clean it with a sterile alcohol wipe and allow it to dry before recapping.

Inconsistent Dosing

Eye drops work best when given at consistent intervals. Missing doses allows bacterial growth or inflammation to rebound. Set reminders or integrate dosing into a daily routine such as meal times.

Not Completing the Course

Antibiotic drops should be continued for the full prescribed course even if the eye looks normal. Stopping early can select for resistant bacteria and cause a relapse.

Handling That Causes Injury

A struggling dog can injure its own eye or bite the handler. If the dog resists strongly, stop and seek help. Your veterinary team can demonstrate restraint techniques or recommend alternatives such as an Elizabethan collar to prevent self-trauma.

Welfare and Safety Context

Eye conditions are painful. Squinting, tearing, and pawing at the eye are signs of discomfort. Prompt veterinary attention and consistent treatment relieve pain and protect vision. The World Organisation for Animal Health recognizes that animal health and welfare depend on responsible medication use and appropriate veterinary care. Owners have a duty to seek veterinary advice when their dog shows signs of eye disease.

Systemic absorption of eye drops is possible. The conjunctiva is highly vascular, and some medications pass into the bloodstream. This is the basis for using eye drops to deliver systemic medications in some species. A case report described central diabetes insipidus in a young dog treated with desmopressin acetate eye drops, with clinical signs resolving after the dose was adjusted. A study in beagle dogs found that palonosetron, an anti-nausea medication, was rapidly absorbed from eye drops, with plasma concentrations similar to intravenous administration within ten minutes. These examples show that eye drops are not purely local treatments. They can have systemic effects, which is another reason to use only medications prescribed by a veterinarian and to report any unusual signs to your veterinarian.

Some eye drops can cause cardiovascular effects. A case report described intraoperative cardiovascular instability in a child following instillation of phenylephrine eye drops. While this report is from human medicine, it illustrates that eye drops can have significant systemic effects. Use only the prescribed dose and do not increase frequency without veterinary direction.

Chemical injuries to the eye require immediate veterinary attention. A case report described a chemical alkali burn in a dog's eye. Alkali burns are particularly damaging because they penetrate the cornea and can cause severe intraocular damage. If a chemical gets into a dog's eye, flush the eye with copious amounts of clean water or saline and seek veterinary care immediately.

Professional Escalation Criteria

Seek immediate veterinary care if any of the following are present:

• The dog is in obvious pain, such as constant squinting, crying, or refusal to open the eye
• The cornea appears cloudy, white, or has a visible defect
• There is a foreign body visible in the eye
• The eye is protruding or the pupil is an abnormal size or shape
• There is blood in the eye
• The dog has suffered trauma to the eye or face
• A chemical has entered the eye
• The dog has suddenly lost vision

Contact your veterinarian during regular hours if any of the following are present:

• Redness or discharge that persists for more than 24 hours
• Squinting or excessive tearing
• The dog is pawing at the eye
• The eye looks different from the other eye
• The dog has a known eye condition and signs are not improving after two to three days of treatment
• The dog is reluctant to eat or is lethargic

If you are unable to administer eye drops despite multiple attempts, contact your veterinary clinic for advice. They may be able to demonstrate a different technique or prescribe an alternative formulation such as an ointment, which can be easier to apply in some dogs.

Building a Treatment Response Monitoring System for Canine Eye Drop Therapy

Tracking response to eye drop treatment is as important as giving the medication correctly. Owners who keep structured records can detect improvement, stagnation, or deterioration earlier than those who rely on memory. This section provides a practical framework for monitoring a dog's response to eye drop therapy, distinguishing between expected and concerning changes, and communicating effectively with the veterinarian.

Why Structured Monitoring Matters

Eye conditions evolve over days and weeks. A single examination provides a snapshot, but the trajectory of the disease determines whether treatment is working. Dogs cannot describe their symptoms, so owners must become reliable observers. Structured monitoring turns subjective impressions into comparable data points that support clinical decisions.

The Merck Veterinary Manual emphasizes that ophthalmic examination findings must be interpreted in the context of the complete clinical picture. Owner observations between examinations provide that context. Without a record system, owners tend to remember the most recent appearance of the eye instead of the trend over time. A dog that improved for two weeks and then worsened may appear to be doing poorly if only the last few days are remembered. Written records reveal the pattern.

The Daily Eye Score System

A simple scoring system allows owners to track clinical signs consistently. Score each of the following categories daily at the same time, ideally before the first dose of eye drops. Use a scale of 0 to 3 for each category, where 0 is normal and 3 is severe.

Record the date, time, and total score in a notebook or a simple spreadsheet. A total score of 0 to 2 indicates a comfortable eye. A score of 5 or higher warrants a call to the veterinarian. A sudden increase of 3 or more points from the previous day requires prompt veterinary attention.

Measuring Tear Production at Home

The Schirmer tear test is the standard diagnostic measurement for dry eye. It is performed by placing a calibrated filter paper strip in the lower eyelid for one minute and measuring the length of wetting in millimeters. Normal values are typically above 15 mm/min. Values below 10 mm/min are consistent with keratoconjunctivitis sicca.

Schirmer tear test strips are available for purchase without a prescription in many regions. Owners of dogs with diagnosed dry eye can learn to perform this test at home under veterinary guidance. The Merck Veterinary Manual describes the Schirmer tear test as a routine part of the ophthalmic examination. Performing this test weekly at home provides objective data on tear production that complements the daily eye score.

To perform the test, gently pull down the lower eyelid and place the folded end of the strip in the lower conjunctival sac. Hold the strip in place for exactly one minute. Remove the strip and read the wetting length against the millimeter scale on the strip. Record the value and the time of day. Tear production can vary slightly throughout the day, so perform the test at the same time each week.

A 2016 study comparing tacrolimus and cyclosporine eye drops for canine keratoconjunctivitis sicca used Schirmer tear test I values to categorize disease severity and monitor treatment response. The study found significant increases in Schirmer tear test values after one and two months of treatment with tacrolimus, and after two months with cyclosporine. This demonstrates that tear production changes measurably over weeks of treatment, making periodic measurement a useful monitoring tool.

Tracking Medication Administration

Accurate medication records prevent dosing errors and help identify causes of treatment failure. Maintain a log that includes the following for each dose:

• Date and time of administration
• Eye treated (left, right, or both)
• Medication name and concentration
• Number of drops or amount of ointment
• Whether the dose was successfully administered
• Any difficulty with administration
• Any signs of discomfort during or after administration

This log serves multiple purposes. It confirms that the dog received the prescribed number of doses. It identifies patterns of missed doses that may explain poor response. It documents any adverse reactions that should be reported to the veterinarian. It also provides a complete medication history if a second opinion is sought.

Recognizing Expected Treatment Response Patterns

Different eye conditions respond to treatment at different rates. Understanding the expected timeline helps owners distinguish normal progress from treatment failure.

For bacterial conjunctivitis treated with antibiotic drops, improvement is typically seen within 48 to 72 hours. Discharge should decrease, redness should fade, and the dog should appear more comfortable. If there is no improvement after three days of treatment, the veterinarian should be notified. The infection may be resistant to the prescribed antibiotic, or the diagnosis may be incorrect.

For corneal ulcers, the first 24 to 48 hours of treatment focus on preventing infection and relieving pain. The ulcer should begin to heal within a few days. Complete healing of a simple ulcer typically takes five to seven days. The veterinarian will usually recheck the eye with fluorescein stain to confirm that the ulcer has closed. If the ulcer is not healing or is getting worse, this is an emergency.

For keratoconjunctivitis sicca treated with immunomodulating drops, the response is slower. A 1989 study of topical cyclosporine in 36 dogs with spontaneous KCS found that cyclosporine increased tear production by 5 mm/min or greater in all cases with an initial Schirmer tear test value greater than 2 mm/min, and in 59% of eyes with an initial value of 0 to 2 mm/min. However, this improvement developed over weeks of treatment. Owners should not expect dramatic changes in the first few days. The daily eye score may improve before the Schirmer tear test value increases, because reduced inflammation and improved tear quality can occur before tear quantity increases.

A 2009 study comparing pimecrolimus eye drops with cyclosporine A ointment for KCS found that the mean increase in Schirmer tear test after eight weeks of treatment was 9.2 mm/min in the pimecrolimus group and 5.8 mm/min in the cyclosporine group. This illustrates that meaningful improvements in tear production develop over a two-month period. Owners should plan for a minimum of four to eight weeks of treatment before judging whether an immunomodulating medication is effective.

Identifying Treatment Failure

Treatment failure can take several forms. The eye may fail to improve, may worsen, or may improve initially and then deteriorate. Each pattern has different implications.

No improvement after an appropriate trial period suggests the diagnosis may be incorrect, the medication may be ineffective, or the dose may be inadequate. For KCS, a 2022 study of topical mesenchymal stem cell therapy noted that some patients are unresponsive to prior immunosuppressant therapy. In that study, 56.5% of patients that were unresponsive to prior immunosuppressant therapy had an effective increase in tear volume after stem cell treatment. This indicates that alternative treatments exist for dogs that do not respond to standard immunomodulating therapy.

Worsening of clinical signs during treatment requires immediate veterinary attention. This can indicate progression of the underlying disease, development of a secondary infection, or an adverse reaction to the medication. Do not continue treatment and wait for the next scheduled appointment. Contact the veterinarian the same day.

Initial improvement followed by deterioration can indicate several problems. The medication may have been discontinued too early. The underlying disease may have progressed. A new problem such as a corneal ulcer may have developed. The medication may have become contaminated or expired. Review the medication log to check for missed doses, contamination events, or storage errors.

The Withdrawal Risk Assessment

For dogs with KCS on long-term immunomodulating treatment, owners should understand the risks of stopping medication. A 2021 study examined the effect of withdrawing chronic topical immune modulating treatment in 14 dogs with dry eye disease. After discontinuation, 50% of eyes maintained Schirmer tear test values above 10 mm/min during a follow-up period averaging 136 days. The other 50% showed a decrease from a mean of 15.9 mm/min to 6.1 mm/min, with the time to drop below 10 mm/min averaging 21 days.

This study has direct implications for monitoring. If a veterinarian recommends reducing or stopping immunomodulating treatment, the owner should increase monitoring frequency. Perform the Schirmer tear test weekly and the daily eye score daily. If the Schirmer tear test value drops below 10 mm/min or the eye score increases by 3 or more points, contact the veterinarian. Early detection of declining tear production allows treatment to be restarted before clinical signs become severe.

The study also found that severe clinical signs of dry eye and low baseline Schirmer tear test values before treatment predicted a faster decline after treatment withdrawal. Dogs with severe KCS are at higher risk of rapid relapse and should be monitored most closely.

Communicating Monitoring Data to the Veterinarian

Bring the monitoring records to every veterinary appointment. The veterinarian can review the daily eye scores, Schirmer tear test values, and medication logs to assess treatment response. This information is particularly valuable when the veterinarian is deciding whether to continue, change, or stop a medication.

When reporting concerns by phone, be specific. Instead of saying the eye looks worse, describe what changed. For example, the discharge increased from a score of 1 to a score of 3, or the Schirmer tear test value dropped from 14 mm/min to 8 mm/min. Specific observations help the veterinary team determine the urgency of the situation.

Photographs and videos are useful supplements to written records. Take a photo of the eye in good lighting each day. A series of photos over time can reveal subtle changes that are difficult to describe in words. Video of the dog squinting or pawing at the eye can help the veterinarian assess pain levels.

When to Escalate Monitoring to Veterinary Examination

The daily eye score and home Schirmer tear test are screening tools, not diagnostic tests. They help owners identify problems early, but they cannot replace veterinary examination. Schedule a veterinary recheck at the intervals recommended by the veterinarian, typically one to two weeks after starting treatment for acute conditions and every one to three months for chronic conditions such as KCS.

Seek immediate veterinary care if any of the following occur during home monitoring:

• The daily eye score increases by 3 or more points from the previous day
• The total daily eye score is 5 or higher
• The Schirmer tear test value drops below 10 mm/min in a dog previously controlled above that level
• The cornea becomes cloudy or develops a visible defect
• The dog shows signs of severe pain such as holding the eye closed or crying
• Blood appears in the eye
• The dog suffers trauma to the eye or face
• A chemical enters the eye

These criteria are escalation triggers, not diagnostic conclusions. They indicate that the situation requires professional assessment. The World Organisation for Animal Health recognizes that animal health and welfare depend on appropriate veterinary care. Timely escalation of concerning findings is a core responsibility of the owner.

Frequently Asked Questions

Can I use human eye drops on my dog?

No. Human eye drops may contain active ingredients, preservatives, or concentrations that are irritating or toxic to dogs. Some human glaucoma medications are highly toxic to dogs. Only use eye drops that your veterinarian has prescribed for your dog.

What is the green discharge in my dog's eye?

Green or yellow discharge from the eye can indicate bacterial infection, but it can also be a sign of dry eye. Dogs with keratoconjunctivitis sicca often have thick mucoid or mucopurulent discharge because the tear film is abnormal. A veterinary examination is needed to determine the cause and prescribe appropriate treatment.

How do I know if my dog has an eye infection?

Signs of eye infection include redness of the conjunctiva, discharge that may be clear, yellow, or green, squinting, and pawing at the eye. These signs can also be caused by corneal ulcers, dry eye, or uveitis. A veterinary examination is required to confirm the diagnosis and rule out more serious conditions.

How often should I give my dog eye drops?

The frequency of administration depends on the medication and the condition being treated. Some drops are given once daily, others three or four times daily. Follow your veterinarian's instructions exactly. If you miss a dose, do not double the next dose unless your veterinarian has instructed you to do so.

What should I do if my dog refuses to let me give eye drops?

Stop and take a break. Forcing the issue can make the dog more resistant and increase the risk of injury. Try a different restraint technique, have a second person help, or use positive reinforcement with treats. If the dog continues to resist, contact your veterinary clinic for advice. They may recommend a different formulation or demonstrate a safer technique.

How long does dry eye treatment take to work?

Immunomodulating treatment for dry eye is slow-acting. Some dogs show improvement in tear production within a few weeks, but full effect may take one to two months. Clinical studies of cyclosporine, tacrolimus, and pimecrolimus have shown significant improvements in Schirmer tear test values after one to two months of treatment. Continue the medication as prescribed even if you do not see immediate improvement.

Can dry eye be cured?

Dry eye is usually a lifelong condition that requires ongoing treatment. Stopping immunomodulating treatment often leads to recurrence of clinical signs. In one study, half of eyes maintained adequate tear production after stopping treatment, but the other half declined to below 10 mm/min within about three weeks. Most dogs with dry eye need long-term or lifelong medication.

What should I do if my dog's eye looks worse after starting eye drops?

Stop the medication and contact your veterinarian immediately. Worsening signs can indicate an incorrect diagnosis, an adverse reaction to the medication, or progression of the underlying disease. Do not wait to see if the eye improves on its own.

Related Veterinary Guides

• Allergic Conjunctivitis In Dogs: Comprehensive Veterinary Reference Guide
• Equine Ophthalmology: Common Eye Conditions and Treatment
• Dry Flaky Skin On Dogs: Comprehensive Veterinary Reference Guide
• Canine Inflammatory Bowel Disease: Diagnosis and Dietary Management
• Can You Use Human Dry Shampoo On Dogs Skin

References and Further Reading

• Merck Veterinary Manual. Merck Veterinary Manual.
• Animal Health and Welfare. World Organisation for Animal Health.
• Comparative clinical evaluation of tacrolimus and cyclosporine eye drops for the treatment of canine keratoconjunctivitis sicca.. Acta veterinaria Hungarica, 2016.
• Clinical evaluation of pimecrolimus eye drops for treatment of canine keratoconjunctivitis sicca: a comparison with cyclosporine A.. Veterinary journal (London, England : 1997), 2009.
• Comparison of the efficacy of 0.03% tacrolimus eye drops diluted in olive oil and linseed oil for the treatment of keratoconjunctivitis sicca in dogs.. Arquivos brasileiros de oftalmologia, 2018.
• Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops.. Archives of ophthalmology (Chicago, Ill. : 1960), 1989.
• Comparison of cyclosporin A and dexamethasone in the treatment of canine nictitans plasmacytic conjunctivitis.. The Veterinary record, 1999.
• Characteristics of a canine model of KCS: effective treatment with topical cyclosporine.. Advances in experimental medicine and biology, 1994.
• Topical applications of allogeneic adipose-derived mesenchymal stem cells ameliorate the canine keratoconjunctivitis sicca.. BMC veterinary research, 2022.
• Effect of Withdrawing Chronic Topical Immune Modulating Treatment on Schirmer Tear Test Values in Dogs with Dry Eye Disease: Relevance to Dry Eye Studies.. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2021.
• A liposomal formulation of cyclosporine a shows promising results in treating symptoms of moderate to severe dry eye disease in dogs.. 2026.
• Diagnostic Ophthalmology.. 2025.
• Conjunctival transforming growth factor-β2 and vascular endothelial growth factor in canine keratoconjunctivitis sicca: Baseline alterations, clinical associations, and response to 0.2% cyclosporine therapy.. 2026.
• Topical Application of Preserved and Unpreserved Bevacizumab Eye Drops Improves Ocular Surface Parameters in Dogs with Chronic Keratitis: A Pilot Study.. 2026.
• Tear Protein Alteration in Dogs with Keratoconjunctivitis Sicca.. 2026.
• Intraoperative Cardiovascular Instability in a Child Following Instillation of Phenylephrine Eye Drops. 2021.
• A case of chemical/ alkali burn in the eye of a dog. 2020.
• Central diabetes insipidus in a young dog - case report. Arquivo Brasileiro de Medicina Veterinária e Zootecnia, 2025.
• Ocular Administration of Palonosetron in the Prevention of Cisplatin-Induced Nausea and Vomiting. Journal of Pharmacology and Experimental Therapeutics, 2023.
• Cherry Eye: Prolapse of Third Eyelid Gland in Dog- A Case Report. 2013.

This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.